-
Fmoc-3-(2-Naphthyl)-L-alanine 112883-43-9
Lorem vestibulum ac copia biopharmaceutical |Raw Materials |Pharmaceutical Intermedia Reagents |Immunology |Peptide synthesis |Amino acid series |Fmoc-3-(2-Naphthyl)-L-alanine |CAS:112883-43-9 |C28H23NO4
-
Fmoc-Trp(Boc)-OH 143824-78-6
Lorem vestibulum ac copia biopharmaceutical |Raw Materials |Pharmaceutical Intermedia Reagents |Immunology |Peptide synthesis |Fmoc-Trp(Boc)-OH |CAS:143824-78-6 |C31H30N2O6
-
Fmoc-L-Leucine 35661-60-0
Lorem vestibulum ac copia biopharmaceutical |Raw Materials |Pharmaceutical Intermedia Reagents |Immunology |Peptide synthesis |Amino acid series |Fmoc-L-Leucine |CAS:35661-60-0 |C21H23NO4
-
Fmoc-D-leucine 114360-54-2
Lorem vestibulum ac copia biopharmaceutical |Raw Materials |Pharmaceutical Intermedia Reagents |Immunology |Peptide synthesis |Amino acid series |Fmoc-D-leucine |CAS:114360-54-2 |C21H23NO4
-
N6.
Lorem vestibulum ac copia biopharmaceutical |Raw Materials |Pharmaceutical Intermedia Reagents |Immunology |Peptide synthesis |N6-[(1,1-Dimethylethoxy)carbonyl]-N2-[(9H-fluoren-9-ylmethoxy)carbonyl]-2-methyl-L-lysine |CAS:12202003-49-3 |C27H34N2O6
-
![O-[2-[[[(1,1-Dimethylethoxy) carbonyl]amino]ethyl]-N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-tyrosinum 1013883-02-7](https://www.yisunbio.com/uploads/29-300x115.jpg)
O-[2-[[[(1,1-Dimethylethoxy) carbonyl]amino]ethyl]-N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-tyrosinum 1013883-02-7
Lorem vestibulum ac copia biopharmaceutical |Raw Materials |Pharmaceutical Intermedia Reagents |Immunology |Peptide synthesis |O-[2-[[(1,1-Dimethylethoxy)carbonyl]amino]ethyl]-N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-tyrosinum |CAS:1013883-02-7 |C31H34N2O7
-
Acidum hippuricum 495-69-2
Lorem vestibulum ac copia biopharmaceutical |Raw Materials |Pharmaceutical Intermedia Reagents |Immunology |Peptide synthesis |Acidum hippuricum |CAS:495-69-2 |C9H9NO3
-
Valsartan 137862-53-4
Lorem vestibulum ac copia biopharmaceutical |Chemical Reagents |Rudis materiae chemica |Pharmacopolium industriale medium |Cardiovascular |Hypertension curatio |Valsartan Intermedia |Valsartan |CAS:137862-53-4 |C24H29N5O3
-
L-Valine methyl ester hydrochloride 6306-52-1
Lorem vestibulum ac copia biopharmaceutical |Chemical Reagents |Rudis materiae chemica |Pharmacopolium industriale medium |Cardiovascular |Valsartan Intermedia |L-Valine methyl ester hydrochloride |CAS:6306-52-1 |C6H13NO2.HCl
-
![N-[(2'-Cyano[1,1'-biphenyl]-4-yl)methyl]-L-valine methyl efter hydrochloride 482577-59-3](https://www.yisunbio.com/uploads/34.jpg)
N-[(2'-Cyano[1,1'-biphenyl]-4-yl)methyl]-L-valine methyl efter hydrochloride 482577-59-3
Lorem vestibulum ac copia biopharmaceutical |Chemical Reagents |Rudis materiae chemica |Pharmacopolium industriale medium |Cardiovascular |Hypertension curatio |Valsartan Intermedia |N-[(2'-Cyano[1,1'-biphenyl]-4-yl)methyl]-L-valine methyl ester hydrochloride |CAS:482577-59-3 |C20H22N2O2.HCl
-
Valsartan yl niensis 137863-17-3
Lorem vestibulum ac copia biopharmaceutical |Chemical Reagents |Rudis materiae chemica |Pharmacopolium industriale medium |Cardiovascular |Hypertension curatio |Valsartan Intermedia |N-(1-Oxopentyl)-N-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-L-valine methyl ester |CAS:137863-17-3 |C25H31N5O3
-
(S)-2,4-Dichloro-alpha-(chloromethyl)-benzenemethanol 126534-31-4
Lorem vestibulum ac copia biopharmaceutical |Pharmaceutical Intermedia Reagents |Morbi infectiosi |Dermatologic |Luliconazole Intermedia |(S)-2,4-Dichloro-alpha-(chloromethyl)-benzenemethano |CAS:126534-31-4 |C8H7Cl3O